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Human pluripotent stem cells (hPSCs) are able to self-renew indefinitely and to differentiate into all adult cell types.
hPSCs therefore show potential for application to drug screening, disease modelling and cellular therapies. In order
to meet this potential, culture conditions must be developed that are consistent, defined, scalable, free of animal
products and that facilitate stable self-renewal of hPSCs. Several culture surfaces have recently been reported to
meet many of these criteria although none of them have been widely implemented by the stem cell community
due to issues with validation, reliability and expense. Most hPSC culture surfaces have been derived from extracellular
matrix proteins (ECMPs) and their cell adhesion molecule (CAM) binding motifs. Elucidating the CAM-mediated
cell-surface interactions that are essential for the in vitro maintenance of pluripotency will facilitate the optimisation of
hPSC culture surfaces. Reports indicate that hPSC cultures can be supported by cell-surface interactions through certain
CAM subtypes but not by others. This review summarises the recent reports of defined surfaces for hPSC culture and
focuses on the CAMs and ECMPs involved.
Keywords: Human embryonic stem cells, Induced pluripotent stem cells, Cell adhesion molecules, PluripotencyIntroduction
Human pluripotent stem cells (hPSCs) include embry-
onic stem cells (ESCs) and induced pluripotent stem
cells (iPSCs) and have enormous potential for appli-
cations to drug screening, disease modelling and cellular
therapies [1,2]. These applications will necessitate the use
of cell culture conditions that are consistent, chemically-
defined and/or non-xenogenic for reasons of scale, repro-
ducibility and safety. hPSCs are adherent cells and have
long been cultured on poorly-defined, complex surfaces of
xenogenic origin. Such surfaces present a wide range of
ligands and interact with hPSCs via poorly understood
mechanisms through many different cell adhesion mole-
cules (CAMs) on the cell surface. CAM-ligand interac-
tions are restricted by the types of CAMs and ligands
available and are governed by the physical properties of
the culture surface. Specific CAM-ligand interactions
mediate various intracellular signalling pathways thought
to be involved in maintaining the homeostasis and self-
renewal of hPSCs. The involvement of CAM-mediated* Correspondence: andrew.laslett@csiro.au
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distribution, and reproduction in any mediumintracellular signalling pathways in the maintenance of
hPSCs are addressed in the following reviews [3-5]. A
detailed understanding of the effects of CAM-surface
interactions on hPSC phenotype and behaviour in culture
should facilitate the optimisation of defined culture con-
ditions to support both hPSC self-renewal and somatic
differentiation pathways. A wide variety of chemically-
defined surfaces that engage different CAM subtypes have
been reported to support the long-term self renewal of
hPSCs [for examples 6-13]. It is challenging to elucidate
the roles of CAMs from these reports due to the diverse
physicochemical properties of the culture surfaces as well
as the inter-laboratory variation in cell culture protocols
and in the cell and surface characterisation methods uti-
lised. Non-specific protein adsorption to many “defined”
surfaces can also confound results [14]. Direct compari-
sons between culture surfaces and the hPSCs cultured
thereon are limited and have been focussed on identifying
systems able to support culture of hPSCs as defined by
minimal criteria including gene expression and qualitative
differentiation assays [15-17]. Detailed characterisation
and direct comparison of hPSCs cultured on defined
surfaces that specifically engage different CAMs is re-
quired to elucidate the roles of CAMs in maintainingntral Ltd. This is an open access article distributed under the terms of the
/creativecommons.org/licenses/by/2.0), which permits unrestricted use,
, provided the original work is properly cited.
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reports of defined culture surfaces for hPSC self-
renewal with a focus on the CAMs and extracellular
matrix proteins (ECMPs) thought to be involved in
mediating cell-surface interactions and maintaining
pluripotency (Figure 1).
Human pluripotent stem cells
Pluripotency describes the ability of single cells to differ-
entiate into every cell type in the developing and adult
body [18]. Pluripotent stem cells are also capable of
indefinite self-renewal in vitro under appropriate condi-
tions. hPSCs are therefore a potential cell source for
myriad regenerative medicine approaches and in vitro
disease models, for example hPSC-derived cardiomyo-
cytes could be used to repair damaged tissue following a
myocardial infarction [1,2]. Pluripotency is a complex
state that is maintained in vitro by large transcriptionalFigure 1 Molecular interactions between human pluripotent stem cel
hPSC illustrates molecular interactions with reported hPSC culture surfaces
adhesion molecules (CAMs) are included if they have been reported in hPS
include integrin subtypes α5β1 (green), αvβ5 (red), αvβ3 (purple), α6β1 (blu
proteoglycans (HSPGs; dashed blue lines) and unidentified CAMs (orange).
of vitronectin (yellow/red), GKKQRFRHRNRKG (orange/red), KGGPQVTRGDVF
(CGGKAFDITYVRLKF; purple/navy blue), AG-73 (CGGRKRLQVQLSIRT; yellow/o
The ligands are presented by ECMPs [represented by curved coloured lines
fibronectin (green) collagen (yellow)] or synthetic surfaces (thick black lines
the image complex extracellular matrix extracts (eg. MatrigelTM and Geltrex
adhesion is simplified in the extreme to illustrate homophilic E-cadherin bi
shown to interact with the ECMP line. Where specific CAMs have not been
are represented by orange ovals with a white question mark. This figure is
cell-cell adhesion interactions important for hPSCs and discussed in this revnetworks that are yet to be fully elucidated [reviewed by
19]. Although many genes are involved in the regula-
tion of pluripotency, cell line variation and population
heterogeneity have hampered the identification of reli-
able molecular markers of pluripotency [20,21]. To fur-
ther complicate matters, murine studies have identified
multiple pluripotent states that are maintained by dif-
ferent signalling networks [22]. It has been suggested
that many of the differences between murine pluri-
potent stem cells (mPSCs) and hPSCs could be attrib-
uted to mPSC and hPSC cultures representing different
states of pluripotency and that hPSCs can move be-
tween these states with changes in culture conditions
[22,23]. All of these factors make correct identification
and characterisation of hPSCs a challenging task.
Adequate characterisation of hPSCs is essential for the
unambiguous identification of surfaces capable of sup-
porting hPSC expansion.ls (hPSCs) and culture surfaces. A schematic diagram of a single
through different ligands and CAM subtypes. Specific ligands and cell
C attachment and/or culture studies. CAMs involved in hPSC adhesion
e) and α2β1 (navy blue), E-cadherin (black blocks), heparan sulphate
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range), GRGDSP (green) and laminin E8 fragments (light blue/blue).
: laminin-511 or −322 (blue), laminin-111 (navy blue), vitronectin (red),
) including SynthemaxTM, StemAdhereTM and PMEDSAH. On the left of
TM) are illustrated as combinations of ECMPs, and on the right cell-cell
nding. Where specific ECMP ligands are poorly-defined, CAMs are
identified the orange CAM is used, and undefined, adsorbed ligands
a greatly simplified and stylised representation of the cell-surface and
iew.
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The quality of ongoing hPSC cultures should be regu-
larly assessed. When developing or implementing novel
culture conditions it is important to characterise the
cells thoroughly in order to validate the culture system.
Daily assessment of hPSC cultures should involve visual
observation of characteristic tightly-packed colonies of
cuboidal-shaped cells containing prominent nuclei, mul-
tiple nucleoli and little cytoplasm, with minimal differen-
tiated cell types present as shown in Figure 2 [1].
Proliferation rates of ongoing cultures can be monitored
over time by recording approximate cell seeding dens-
ities and the frequency of passaging, but when compar-
ing various culture conditions the proliferation rate
should be calculated more accurately from serial cell
counts of ongoing cultures at multiple time points.












Figure 2 HPSCs cultured on different surfaces. Schematic diagrams illus
substrates (where appropriate) of the three major types of culture surfaces
(A) Feeder cells, (B) extracellular matrix (ECM) extracts and (C) chemically d
on one example of each surface type, murine embryonic fibroblasts, Geltre
of D-F. hPSCs cultured on each surface display a typical morphology with c
nuclear-to-cytoplasmic ratio.monitoring associated molecular markers. The gold
standard genetic marker of pluripotency is POU domain,
class 5, transcription factor 1 (Pou5f1) aka OCT4, a
homeodomain transcription factor of the POU family
that is essential for pluripotent cells [24]. Expression of
OCT4 and other markers can be assessed in populations
of hPSCs using numerous methods, listed in Table 1
[25-28]. Additional information about the cell state can
be obtained by characterising the epigenetic signature.
Epigenetic regulation of gene expression is exercised
through modifications to the genome that do not affect
the genetic sequence. DNA methylation is one of the
most-studied epigenetic modifications. Methylation down-
regulates expression of local genes and can be detected by
sequencing bisulfite-treated DNA [29]. Signature methyla-
tion patterns can be used to identify developmentally reg-















trate the arrangement of cell adhesion molecules (CAMs), ligands and
used for maintenance of human pluripotent stem cells (hPSCs).
efined culture surfaces. (D-F) Phase contrast images of hPSCs cultured
xTM and Corning SynthemaxTM respectively. (D*-F*) Magnified regions
ompact colonies of cells with prominent nucleoli and high
Table 1 Parameters of interest for hPSC characterisation and methods for their assessment
Parameters Method Strength of evidence of pluripotency
Physical characteristics (daily/weekly) Daily visual assessment of cell/colony
morphology
Weak, subjective
calculate adhesion efficiency, population
doubling time
Expression of molecular markers eg. OCT4,
NANOG, SOX2, REX1 (following passages 1, 5
and >10)
Immunocytochemical staining, flow
cytometry, RT-PCR, microarray assays
Moderate-strong. Depending on marker(s) assessed.
Epigenetic profiling Bisulfite sequencing, ChIP, microarray assays Moderate-strong. Depending on marker(s) assessed.
Differentiation potential
(following >10 passages)
Embryoid body differentiation (in vitro) with




(in vivo) with histological determination of cells
from the three embryonic germ layers
Gold standard
Genetic stability (following >10 passages) G-banding, FISH, SNP analysis Not applicable. Important to identify genetically
transformed cultures, not indicative of
differentiation potential
Physical characteristics, molecular markers, epigenetic profiling, differentiation potential and genetic stability can be assessed by the range of methods listed
(not comprehensive). We recommend the methods highlighted in bold performed at frequencies indicated in the first column as the minimum requirements for
validating novel culture systems. Unbolded methods should also be considered for more thorough characterisation of hPSCs.
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methylation patterns have also been linked to the differen-
tiation potential of hPSCs and can therefore be used as
molecular markers of pluripotency [31]. Molecular mar-
kers are however not completely specific to pluripotent
cells due to the inherent heterogeneity of hPSCs. For
example subpopulations with reduced differentiation po-
tential have been identified within OCT4-positive popula-
tions of hPSCs [21]. While combinatorial assessment of
marker expression improves the robustness of molecular
assays for pluripotency they ultimately remain surrogate
assays, whereas functional demonstrations of cell potential
provide more stringent tests of pluripotency. The ability of
hPSCs to differentiate into cell types of all three embry-
onic germ layers (endoderm, ectoderm and mesoderm)
can be examined both in vitro and in vivo. In vitro differ-
entiation of pluripotent cells is usually associated with the
formation of embryoid bodies [complex, non-adherent,
three-dimensional structures composed of spontaneously
differentiating hPSCs [32,33] and can either be spontan-
eous or directed towards certain cell fates [25,34]. The
in vivo differentiation potential of hPSCs is typically tested
by transplantation into immunodeficient mice. The forma-
tion of a teratoma (a benign tumour comprising cell types
representative of each of the three embryonic germ layers)
at the site of implantation is the most stringent validation
assay available for the differentiation potential of putative
hPSCs [18]. However, differentiation assays are laborious,
inconsistent in efficiency and difficult to standardise
across cell lines and laboratories, so evaluation of molecu-
lar markers remains important for assessing the efficacy of
hPSC culture systems. Quality control of any long-termcell culture system should also include an assessment of
genetic stability using G-banding analysis to detect gross
or subchromosomal changes. However, genetic aberra-
tions below the detection limit of G-banding have been
identified in hPSC lines and more detailed genetic analysis
should also be considered when testing novel culture sys-
tems [35]. A detailed characterisation of hPSCs should in-
clude the methodologies bolded in Table 1.
The evolution of hPSC culture surfaces
It is well known that in vitro maintenance of the pluri-
potent state requires culture in supportive media within
a favourable cellular microenvironment. An important
aspect of the cellular microenvironment is the culture
surface, to which hPSCs are anchored by CAMs. hPSCs
are routinely cultured in vessels containing complex
media and coated with complex surfaces. The signalling
pathways regulated by growth factors in the media and
by ligands on the culture surface converge downstream
and contribute to the maintenance of pluripotency, so
the combination of surface and media is critical. When
the cells reach confluence (usually after 4–7 days) they
are enzymatically dissociated, lifted into suspension and
a portion is transferred into freshly coated vessels to
which they adhere and continue proliferating indefi-
nitely. The most widely used systems for maintaining
hPSCs persist from the early days of hPSC derivation
and rely on a layer of either mitotically-inactivated mouse
embryonic fibroblast (MEF) feeder cells (see Figure 2 A
and D) or complex extracellular matrix (ECM) extracts
including MatrigelTM and GeltrexTM (Figure 2 B and E)
[1,36]. These pluripotency-supporting materials are not
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of pathogens, show batch-to-batch variability and interact
with hPSCs in a poorly-defined way. On the other hand
most practical applications of hPSCs, including potential
use in cell therapies, will demand chemically-defined,
xeno-free culture conditions. Many approaches to impro-
ving hPSC culture surfaces: using human or autologous
feeders [37,38], complex human ECM extracts [39], de-
fined surfaces in combination with conditioned media
(CM) [media imbued with factors secreted by cultured
cells, often MEFs (MEF-CM)] [40] or even fixed MEFs
[41] incompletely address these concerns. A suite of
chemically-defined, xeno-free surfaces (see Figure 2 C and
F) have recently been reported to support hPSC culture in
defined media, although many of these surfaces are expen-
sive and none have been widely employed by the stem cell
community [9,11,42-44]. Defined surfaces that are thought
to specifically interact with different CAM-subtypes have
been reported to support hPSC culture (see Figure 1) but
the roles of CAMs in maintaining pluripotency are poorly
understood. hPSC culture surfaces must be identified that
are reproducible, stable, xeno-free, affordable and that can
be tailored to a range of long-term differentiation proto-
cols. Such surfaces should be based on an understanding
of the properties of the surfaces and of the requirements
of the cells, including CAM-mediated signalling.
Cell adhesion molecules (CAMs) and the maintenance of
pluripotency
Cell adhesion molecules (CAMs) are cell-surface pro-
teins that mediate interactions with nearby cells and
ECMPs through extracellular ligands. When engaged by
a ligand, CAMs transfer molecular signals “outside-in”
to the nucleus of the cell resulting in modification of
gene expression. Signals can also be transferred “inside-
out” when cytoplasmic agonists alter the affinity of CAMs
for certain ligands [reviewed by 45]. A range of CAMs
have been considered as potential molecular markers for
hPSCs and could be involved in the maintenance of pluri-
potency [46]. The main CAM families thought to be in-
volved in hPSC maintenance are integrins and cadherins,
which have each been shown to modulate self-renewal of
hPSCs in culture on different surfaces [23].
Integrins
Integrins are a family of transmembrane heterodimeric
glycoproteins that are composed of α and β chains.
Eighteen α and eight β chains have been identified in
humans, combining to form the twenty-four known
types of integrin [reviewed by 3]. Different integrin types
recognise and bind a range of ligands with various affin-
ities. Bound integrins assemble at the cell surface and
interact with numerous cytoplasmic proteins to form
focal adhesions, which act as transmembrane signallingconduits regulating intracellular kinases and phospha-
tases [3]. The formation of focal adhesions by various
integrin types modulates different downstream signal-
ling pathways that mediate a range of cell responses
and functions. In particular, roles in inner cell mass
formation and cell survival make integrins promising
targets for hPSC culture surfaces [47]. Integrins α5β1
[48], α6β1 [11], αvβ3 and αvβ5 [42] have been reported
to mediate hPSC interactions with several defined cul-
ture surfaces and are thought to be involved in main-
taining pluripotency.Cadherins
Cadherins are transmembrane glycoproteins that form
calcium-dependent cell-cell and cell-ECM homophilic
binding junctions [reviewed by 4]. While the cadherin
family comprises more than 100 members, E-cadherin is
the primary cadherin expressed by hPSCs and its ex-
pression and engagement is important for hPSC function
[49]. Active E-cadherin interacts with multiple intra-
cellular signalling mechanisms and is involved in tissue
morphogenesis, hPSC self-renewal [4] and hPSC mec-
hanosensing of surface nanotopography [50]. Conversely,
disruption of E-cadherin signalling has been linked to
hPSC death following dissociation [23]. Accordingly, re-
duction in E-cadherin expression correlates with early
differentiation processes in vitro [28]. E-cadherin clearly
plays an important role in pluripotency and is therefore
a target CAM for defined hPSC culture surfaces. As a
homophilic binding protein, E-cadherin not only serves
as a CAM for hPSC binding but also as a potential ligand.
A recombinant human fusion protein composed of E-
cadherin and the Fc region of IgG1 antibodies has been
developed as a tissue culture coating for untreated
polystyrene [10]. This fusion protein coating, which
mediates cellular adhesion through the E-cadherin
component, has been reported to support long-term
culture of teratoma-forming hPSCs in combination
with a range of chemically defined media and has been
commercialised as StemAdhereTM [10,43].Extracellular matrix proteins (ECMPs) as ligands for hPSC
culture surfaces
Most defined culture surfaces have been developed though
a reductive approach. Proteomic analyses of complex
culture surfaces like MEFs and MatrigelTM have identi-
fied several ECMPs involved in hPSC culture including
collagen, laminin, fibronectin, vitronectin and heparan
sulphate proteoglycans (HSPGs) [51,52]. The ability of
these ECMPs and their derivative peptides or molecular
mimics, alone or in combination, to maintain hPSC cul-
ture is discussed below. Peptides and molecular mimics
are of particular interest because they mediate fewer
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tion of key interactions.
Collagens
Collagens are large, trimeric proteins that assemble into
fibrils and fibres and comprise the primary structural
component of the extracellular matrix [reviewed by 53].
Collagens contain multiple binding sites that interact with
a wide range of extracellular and cell surface proteins
thought to be linked to pluripotency, including various
integrins and HSPGs [reviewed by 54]. These binding sites
and interactions suggest that collagen may be a suitable
surface for hPSC culture; however in practice the demon-
strated ability of collagen to support hPSCs has been lim-
ited. In a 5-day culture experiment collagen subtypes I, III
and IV were able to support adhesion and proliferation of
hPSCs in MEF-CM, although proliferation did not occur
consistently on all subtypes or with all cell lines [15]. In
longer-term studies MEF-CM (but not defined medium)
has been shown to support OCT4 positive hPSC colonies
on collagen IV for at least five passages [7], but not on
collagen I due to poor attachment [40]. Medium that was
conditioned by cells derived from an embryoid-body
culture was able to support OCT4 positive hPSC colonies
on collagen I for at least one month [40]. In the latter
study, media conditioned by two other somatic cell types
failed to support hPSC culture beyond two passages on
MatrigelTM, highlighting the considerable effects that un-
defined components in CM can have on the effectiveness
of a culture system and the importance of defined media
for achieving reproducible cultures. Inclusion of collagen-
derived peptides in cell culture surfaces has not been
reported and the CAMs involved in the hPSC-collagen
interactions have not been investigated, probably due to
the lack of success in maintaining cultures on whole colla-
gen. Curiously, long term culture of hPSCs has been
achieved on gelatin (a derivative of collagen) in heavily-
supplemented serum-free medium that was designed to
emulate mPSC culture conditions [23]. These “converted
hPSCs” could self-renew for more than 20 passages, were
OCT4 positive by immunostaining and demonstrated the
ability to differentiate into cell types of the three embry-
onic germ layers in vitro. The morphology and gene
expression of converted hPSCs was reported to be more
mPSC-like and the CAMs involved in mediating adhesion
shifted from predominantly integrins to E-cadherin [23].
This unique example raises questions about the pheno-
typic stability and adaptability of hPSCs in various culture
conditions and demonstrates the importance of standard-
isation of culture media.
Laminins
Laminins are cruciform, trimeric ECMPs composed of α,
β and γ chains and are major proteins in the basallamina. There are 5α, 4β and 3γ chains that combine to
form the 15 known laminin subtypes. Subtypes are named
for their chain composition, for example laminin-511 is
composed of α5 β1 and γ1 chains. Laminin proteins have
been proposed as hPSC culture surfaces due to their
prominence in more complex surfaces [52] and because
they contain multiple cell-binding motifs including RGD,
E8, IKVAV, AG-10, C-16 and AG-73 [55,56] that interact
with various integrins and proteoglycans expressed by
hPSCs [57]. Mixed-subtype human laminin has main-
tained self-renewing, teratoma-forming hPSCs in several
conditioned and defined media over long-term culture
and during the establishment of hESC cell lines [58,59].
Five of the fifteen laminin subtypes have since been tested
as hPSC culture surfaces coupled with the use of MEF-
CM. In two independent studies laminins-511, -322 and
−111 (which all interact with integrin α6β1) supported
culture of OCT4 positive hPSCs capable of in vitro differ-
entiation into the three germ layers for at least 10 pas-
sages, while laminins-211 (α3β1) and −411 (α7β1) failed to
even support adhesion [11,60]. Laminin-511 is the most
thoroughly tested subtype and has been demonstrated
to support long-term hPSC culture in three different
chemically-defined media and further to support hESC
derivation [11,61].
Several peptides derived from laminin-111 have been in-
corporated into hPSC culture surfaces with varying results.
In adhesion studies a peptide (RNIAEIIKDI) derived from
the γ-chain successfully mediated attachment of hPSCs
in defined xeno-free media while an IKVAV-containing
peptide bound hPSCs poorly [9,62]. Other laminin-
111-derived peptides (AG-10, C-16, AG-73) have mediated
adhesion of hPSCs in defined media by engaging different
integrin subtypes or heparan sulphates [57]. These small
peptides were only able to support hPSCs for a few pas-
sages when presented together in specific proportions,
with differentiation apparent by the third passage [57].
More recently, larger laminin fragments composed of
three post-translationally modified polypeptide sub-
units that form the E8 binding sites [63] of laminins-
332 and −511 have been reported to support the long
term culture of teratoma-forming hPSCs in a range of
defined media [13]. E8 fragments demonstrated a stron-
ger adhesion affinity to hPSCs than either MatrigelTM or
the whole laminins from which they were derived,
which is a promising finding for the application of func-
tional subunits to replace whole ECMPs in defined sur-
faces for hPSC culture [13]. The mixed reports of hPSC
culture on laminin-derived subunits reflect how hPSCs
can attach to different binding sites on single ECMPs
with different affinities and that the maintenance of
pluripotency depends on properties of CAM-mediated
interactions with the culture surface beyond simple
adherence.
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Fibronectin subunits are large (~250 kDa) extracellular
glycoproteins which form disulfide-bonded dimers and
much larger fibrils [64]. Fibronectin is ubiquitously ex-
pressed throughout the developing and adult body and
plays an organisational role in assembling other ECMPs
[reviewed by 65]. In theory fibronectin is a promising can-
didate surface for hPSC culture because it contains many
binding domains that interact with ECMPs and CAMs
associated with the self-renewal of hPSCs including fibrin,
collagen, heparan sulfates and integrins [65]. In practice
fibronectin has been favourably compared to laminin for
its ability to support hPSC adherence and maintenance of
pluripotency [15,66]. Whole fibronectin has been reported
to maintain long term cultures of OCT4 positive hPSCs
capable of in vitro differentiation into the three germ
layers and/or teratoma formation in MEF-conditioned
[66] or heavily supplemented serum-free media [48] and
also in several chemically-defined media [6,67,68].
Fibronectin-cell interactions are predominantly medi-
ated by the GRGDSP motif and its interaction with α5β1
integrins [69]; the key role of α5β1 integrins in hPSC-
fibronectin adhesion has been supported by a competitive
inhibition study [48]. Nevertheless, defined surfaces that
presented two fibronectin-derived, GRGDSP-containing,
α5β1-binding peptides gave poor hPSC adhesion, suggest-
ing that the ability of fibronectin to support hPSC culture
relies on multiple binding domains [9]. A larger fusion
peptide-amphiphile developed by Mardilovich et al., [70]
and containing a GRGDSP motif has shown comparable
adhesion and specificity to fibronectin in endothelial cell
culture, although the ability of this peptide to support
hPSCs in long term culture has not been reported [70].
Considering the success of whole fibronectin as a hPSC cul-
ture surface it remains of interest to determine whether this
and other fibronectin-derived peptides can support the
maintenance of hPSCs.
Vitronectin
Human vitronectin is a relatively small (75 kDa) glyco-
protein that can be secreted as either a single chain or a
dimer, is abundant in blood and throughout the ECM
and promotes cell adhesion and migration [reviewed by
71]. Vitronectin contains multiple binding sites that en-
gage integrins or HSPGs, which positions vitronectin as
one of the most promising ECMPs for hPSC culture [72].
The potential applications of vitronectin to hPSC culture
are exemplified by a vitronectin-containing chimeric pro-
tein that has been used as a media supplement for hPSC
culture on a laminin-coated surface [61]. Vitronectin-
coated tissue culture polystyrene (TCP) has supported
long-term culture of teratoma-forming hPSCs [7,12,73,74]
and hiPSC derivation [75,76] in a range of conditioned
and defined media. Only two groups have reported thefailure of vitronectin-based surfaces to maintain the pluri-
potency of cultured hPSCs in appropriate media and these
results were probably due to inadequate deposition of the
vitronectin protein [16,77]. Hakala et al., [16] were unable
to maintain hPSC culture on vitronectin-coated TCP and
Abraham et al., [77] on a surface composed of vitronectin
and HSPG (vitronectin-alone was not tested). Both studies
used lower concentrations of vitronectin (200 ng/cm2 and
10 ng/cm2 respectively) than the threshold for hPSC cul-
ture of 250 ng/cm2 that was later determined by Yap et al.,
[73]. Since neither study reports surface characterisation
such as performed by Yap et al., [73] we must assume that
concentrations were calculated based on the vitronectin
concentration in solution and assuming 100% depos-
ition. Thus the actual protein surface concentrations in
these studies would have been well below the threshold,
explaining the inability of these culture systems to
maintain hPSCs.
As implied by the binding sites described above,
hPSC-vitronectin adhesion is mediated by αvβ3/β5
integrins and HSPGs [8,42]. Accordingly, two integrin-
binding peptides and one HSPG-binding peptide derived
from vitronectin have been individually demonstrated to
support long-term culture of teratoma-forming hPSCs
[8,9,78]. The subtype-specificity of the integrin-binding
peptides was not assessed, although anchored small mol-
ecules that specifically bind αvβ3 integrins have failed to
support hPSC adhesion [79]. The latter small-molecule
data is difficult to interpret without side-by-side and
combinatorial comparisons with other integrin-specific
small molecules. The apparent functional redundancy
within the vitronectin molecule has demonstrated that
small peptides can be sufficient to mimic the hPSC-
supporting effects of ECMPs and suggests that the main-
tenance of pluripotency may not depend entirely on
specific CAM-ligand interactions.
Combinations of ECMPs as hPSC culture surfaces
Combinations of collagens, fibronectin, laminins and
vitronectin have been reported to support long-term cul-
ture of hPSCs in a few studies [15,80], although combin-
ing ECMPs in this way can be superfluous given the
aforementioned abilities of single-ECMPs (especially
vitronectin and laminin-511) to support hPSCs. In one
study, hPSCs cultured on a fibronectin-coated surface
became differentiated after fewer than five passages
while a fibronectin + HSPG surface supported culture of
alkaline phosphatase-positive cells without morpho-
logical differentiation [77]. The initial experiments were
conducted in a serum-free medium that had been sup-
plemented with 4 ng/ml basic fibroblast growth factor
(FGF-2) and although cells proliferated on fibronectin-
HSPG in this medium and expressed alkaline phosphatase
they would not differentiate when induced [77]. In the
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peated using media supplemented with additional FGF-2
(100 ng/ml) and the maintenance of pluripotency was
demonstrated by successful embryoid body formation. It
is unclear if the fibronectin-alone culture was repeated
with the higher concentration of FGF-2 in this study [77].
These results contrast with other reports of hPSCs being
maintained long-term on fibronectin using defined media
and highlight the need for investigation of key signalling
pathways involved in the maintenance of pluripotency and
the importance of standardisation of defined culture
methods [48,66,68,81].
Surfaces that interact with hPSCs through non-specific
adsorbed media proteins
Some surfaces capable of supporting hPSC culture contain
no obvious ligands; these surfaces usually rely on a level of
culture medium and/or hPSC-secreted protein adsorption
(protein-fouling) to mediate adhesion [14,82]. Although
protein-fouling surfaces may lack native ligands they often
have modifiable physical properties which can be used to
control cell behaviour and to optimise the adsorption of
protein or peptide ligands (discussed further below). In one
unusual report, Bigdeli et al., [83] reported the culture of
two hPSC lines directly on TCP in a neonatal chondrocyte-
conditioned medium (NC-CM). Media conditioned by
several different somatic cell types were trialled, but only
NC-CM supported effective adhesion and ongoing culture
[83]. It would be interesting to determine which factor se-
creted by the neonatal chondrocytes was critical to this re-
sult. Adaptation to these culture conditions involved high
levels of cell death and required an unusually long (20-day)
recovery period. Nevertheless the cells were maintained
long-term, thoroughly characterised for gene expression and
differentiation potential and no genetic abnormalities were
detected in either cell line by G-banding or FISH analysis.
However, culturing hPSCs directly onto polystyrene has not
been reproduced by other groups and the hPSC lines used
(SA167 and AS034.1) have not been reported in any other
culture surface studies and may behave uniquely [83].
While protein-fouling surfaces may adequately support
hPSC culture they cannot be used to investigate critical
molecular signalling pathways due to their poorly defined
cell-surface interactions. Another consideration for these
surfaces is that the type and concentration of adsorbing
proteins may vary between cell lines and media formula-
tions. A surface that depends on adsorbed proteins to me-
diate adhesion may be vulnerable to these variations and
is likely to vary in its effectiveness at supporting different
cell lines [84].
Two-dimensional substrates for hPSC culture surfaces
In many of the aforementioned culture systems, the
CAM-engaging proteins or peptides are simply appliedto TCP in aqueous solutions from which they adsorb
onto the plastic e.g. [7,57]. However physicochemical
modifications to TCP and more complex substrates in-
cluding self-assembled monolayers (SAMs), polymer
scaffolds and hydrogels are also being developed to opti-
mise surface properties including hardness [85], rough-
ness [50], stiffness, wettability [42] and ligand density
[8], distribution [9] and presentation [86]. Some alter-
ations to the physical properties of culture substrates
{eg. nanoroughness [50]} are thought to be recognised
directly by hPSCs while others such as wettability affect
the adsorption and presentation of media and secreted
proteins [87], indirectly influencing CAM-mediated cell-
surface interactions.
Characterisation methods for hPSC culture surfaces
In order to optimise hPSC culture surfaces the physical
characteristics of the surfaces must be tuned to optimise
CAM-ligand interactions. The effects of modulation of
various physical properties on hPSC culture and detailed
descriptions of methods to characterise these properties
are beyond the scope of this review. In lieu of that,
Table 2 is intended to create awareness in cellular biolo-
gists of the range of methods available and appropriate
for this non-biological but very important aspect of de-
veloping synthetic culture surfaces for hPSC culture. It
is worth noting here that it remains a challenge to con-
trol and characterise the quantity, distribution and
orientation of ligands bound to polymer surfaces. Since
these properties influence CAM-ligand interactions it is
of interest to the field to develop new technologies to
evaluate them. Throughout the following discussion on
hPSC culture substrates, a “substrate” is defined as the
non-ligand parts of a surface, those parts that position
and present ligands rather than directly engaging CAMs.
Modifications to plastic and glass culture surfaces
Simple modifications that have been used to make TCP
or glass more biologically relevant for hPSC culture in-
clude amine-modifications [86] and physicochemical
damage caused by UV-treatment [12], plasma-etching
[82] or reactive ion etching [50]. These modifications
increase the hydrophilicity, change the nanoscale topog-
raphy and/or increase the abundance of functional groups
on the surface, which can all modulate cell-surface inter-
actions either through modulation of protein adsorption
or by allowing modification with specific ligands.
Self assembled monolayers (SAMs)
Biologically-relevant self assembled monolayers (SAMs)
are typically comprised of derivatives of organic alka-
nethiol (AT) molecules, which spontaneously form a
monolayer on gold films comprehensively [reviewed by
88]. The thiol head groups bind to the gold film and the
Table 2 Parameters of interest for characterisation of hPSC culture surfaces and analytical methods for their assessment
Parameter Analysis method Pros Cons
Surface topography Atomic force microscopy
(tapping mode)
Compatible with an aqueous environment, can view individual
proteins that have absorbed to the surface, modern instruments
acquire images at a faster rate.
Images are generally of a small area, therefore may not be representative.
Scanning or transmission
electron microscopy
Widely available Resolution is not as high, significant sample preparation is required, unable
to quantify topography.





Relatively straightforward assay Microenvironment and dye-dye quenching effects from surface anchored









Quantitative, sensitive, relatively straightforward assay Need to carry out chemical coupling of Eu-chelate to ligand.
Radio-labelling of ligand Quantitative, sensitive, relatively straightforward assay Complex chemistry required to either radio-label pre-synthesised ligands or
synthesise ligand with radioisotope-containing precursors.
Chemical properties Nuclear magnetic
resonance (NMR)
Straightforward sample preparation Solid-state NMR generally not sensitive enough, complex spectra.






Elemental composition quantitative, sample preparation is very
simple (removal of buffer salts and drying).
Elemental composition is straightforward but high resolution spectra
complex, amide bond-containing materials generate false positives, no
specificity in relation to protein type, ultra high vacuum technique
(can cause structural rearrangements).
Time-of-flight secondary
ion mass spectrometry
Minimally-destructive, minimal sample preparation, efficient, Analysis generally not quantitative, produces large data sets often requiring
statistical methods, no specificity in relation to protein type, ultra high
vacuum technique (can cause structural rearrangements)
Fourier transform infrared
spectroscopy





Straightforward if embryoid bodies are being generated in house Expensive, time-consuming
HeLa or other e.g. L929
cell adhesion assay
Reliable, cheap if cell lines are available in laboratory Cell attachment for cells other than hPSCs may be mediated by
different ligands.
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dicular to the film. Micropatterning of ATs with modi-
fied carboxyl or hydroxyl tail groups (to present ligands)
and perfluoro-ATs (to provide a protein low-fouling
background) allows presentation of multiple and varied
ligands in particular orientations at controlled densities
and distributions [88]. These customised AT-SAMs have
been used by several groups to culture hPSCs and to in-
vestigate the molecular mechanisms involved in adhe-
sion and maintenance of hPSCs. AT-SAMs have been
used extensively by the Kiessling laboratory (University
of Wisconsin) where laminin- and vitronectin-derived
peptides have been identified that can support short and
long term hPSC culture respectively [8,62]. Micropat-
terned AT-SAMs have also been used to regionalise ad-
sorption of mixed ECMPs onto carboxyl groups presented
in a certain distribution, allowing fine control of hPSC col-
ony size for medium-term (5 passages) culture [89]. Cul-
turing hPSCs on these ECMP-islands resulted in colonies
that were more homogenous for pluripotency marker ex-
pression than MEF-supported control cultures [89].
Although the customisable nature of SAMs makes them
useful for investigating cell adhesion mechanisms, SAMs
are physically unstable under biological conditions, which
limits their utility for long-term hPSC culture and subse-
quent differentiation assays [90]. The gold coatings on
which SAMs assemble can also present a challenge for
visual assessment of live cultures [88]. For these reasons
SAMs are unsuitable for practical applications as a long-
term culture surface and while there is much to be learned
from hPSC culture on SAMs it is currently unclear how
transferrable results from SAM-based studies will be to
other prospective culture surfaces.
Heparan sulfate proteoglycans (HSPGs)
Proteoglycans are large, membrane-bound extracellular
proteins with covalently attached chains of repeating dis-
accharide units called glycosaminoglycans (GAGs). Proteo-
glycans are named according to GAG classes such that
heparan sulphate proteoglycans (HSPGs) include all pro-
teins bound to heparan sulphate polysaccharides {reviewed
by Kim et al [3]}. Different proteoglycan subtypes are found
throughout the mammalian ECM, but HSPGs are the most
relevant to hPSCs and can be exploited in hPSC culture
systems [8,91,92]. HSPGs bind to, stabilise and mediate in-
teractions with integrins expressed by hPSCs [93] and with
growth factors and their receptors. One such growth factor
is FGF-2 [94], a key component of hPSC media which can
mediate hPSC adhesion when immobilised [15]. This co-
operative role of HSPGs is thought to explain why higher
levels of FGF-2 are required to support feeder-free hPSC
cultures when using non-conditioned media [95]. Since
HSPG-hPSC interactions are often mediated by non-HSPG
ligands (eg. FGF-2), for the purposes of investigating themolecular mechanisms involved in maintaining pluripo-
tency HSPGs can be considered as a complex substrate that
optimises presentation of a poorly-defined group of ligands.
Few studies have tested the effects of HSPGs on hPSC
maintenance and differentiation. HSPGs have been shown
to play a role in the differentiation of mPSCs and are not
necessary for maintenance of their pluripotency [96].
However given mPSCs (unlike hPSCs) do not require
FGF-2 signalling to self-renew [97] and predominantly
interact with surfaces through different CAMs to hPSCs
[23], this finding is not likely to be relevant to culture of
conventional hPSCs. HSPG-mediated binding has not
been able to support hPSC attachment on its own, al-
though in combination with fibronectin HSPGs have im-
proved the maintenance of pluripotency in the presence
of higher concentrations of FGF-2, as discussed above
[77]. The need for increased FGF-2 supplementation sug-
gests that the HSPGs were not effectively presenting FGF-
2 in this study or that other inadequacies in the culture
system need to be compensated for [77].
The ability of heparan sulphate (HS) disaccharides to
support hPSC culture has not yet been tested, although
HSPG-binding peptides [8] and HS-mimicking polymers
including poly(sodium 4-styrenesulfonate) (PSS(S)) and
poly[2-(methacryloyloxy)ethyl dimethyl-(3-sulfopropyl)
ammonium hydroxide] (PMEDSAH) have been used to
successfully maintain long-term hPSC culture.
Polymer scaffolds
Polymer scaffolds can be loosely defined as physical net-
works composed of any polymer (long chains composed of
monomer subunits). Polymer scaffolds can be applied to
culture surfaces of various dimensions and their physico-
chemical properties can be tailored to meet the demands of
hPSC cultures [42]. Polymers can interact with hPSCs due
to intrinsic bioactivity or because they have been modified
to present specific ligands. In the latter case, when investi-
gating cell-surface interactions protein low-fouling poly-
mers are preferred to minimize non-specific interactions
with proteins and cells. Polymer scaffolds can also be
employed as a base with controllable physical properties
and then simply pre-coated with ECMPs [42].
The bioactive polymer on which hPSC culture has
been most heavily studied is the zwitterionic PMEDSAH,
which has been reported to support long-term hPSC
culture in a range of conditions but performs most con-
sistently in combination with various CM [44,84,98,99].
The carboxyl and sulfonyl groups in PMEDSAH have
been suggested to mimic HSPGs and to act as a reser-
voir for growth factors including FGF-2; however this
hypothesis has not been tested by surface characterisa-
tion [100]. The reported protein low-fouling properties
of zwitterionic materials that has led to their application
to implantable medical devices only further confounds
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[101]. Reports of PMEDSAH supporting hPSC attach-
ment and culture suggest that PMEDSAH is not protein
low-fouling and it will be treated as such for the remain-
der of this discussion. In serum-free chemically-defined
media PMEDSAH can be an unreliable surface for hPSC
culture and the ability of culture systems to maintain
hPSCs depends on the media and cell-lines [98]. This
inconsistency may be due to lower levels of certain proteins
in defined media limiting the abundance of adsorbed
ligands available for CAM binding. Culture results can
be improved with pre-incubation of plates with FGF-2-
supplemented (4 ng/ml) “human cell” CM (hCCM,
GlobalStem®) and hCCM is also required during adap-
tation from MEF-based culture [44]. Other sulfonyl-
containing polymers trialled as hPSC culture surfaces
include PSS(S), poly(methyl vinyl ether-alt-maleic
anhydride) (PMVE-alt-MA), poly(acrylamido-methyl-
propane sulfonate) (PAMPS) and poly[3-sulfopropyl
methacrylate] [98,100]. PMVE-alt-MA has supported
medium-term culture of several hPSC lines in a defined
medium while PAMPS and PSS(S) enabled attachment
but were unable to support hPSC culture beyond a few
passages [100]. PSS(S) has also been integrated into a
hPSC-supportive hydrogel which is discussed below
[102]. Bioactive polymers that do not contain sulfonyl
have been used to support hPSC culture when coated
with ECMPs. Poly (lactic-co-glycolic acid) (PLGA)
coated with subtype non-specific laminin has been re-
ported to adhere hPSCs [103] while other bioactive
polymers have been able to maintain teratoma-forming
hPSCs in long-term culture when coated with either
vitronectin or human serum [42,104]. Although bio-
active polymers may provide adequate support for
hPSC culture they cannot be used to study cell-surface
interactions because the interactions are mediated by
adsorbed proteins, which can vary between media-type
and cell lines.
Protein low-fouling polymer scaffolds with covalently at-
tached ligands have not yet been reported to support hPSC
culture. Protein low-fouling polymer brushes are promising
substrates for investigating cell-surface interactions because
they can be used to present specific ligands at a controlled
density and in specific orientations. Polymer chains can be
terminally-modified with different peptides using a range
of simple chemistries including “click” chemistries and
the formation of amide bonds. These chemistries can be
tailored to specific peptides and performed under biologically-
relevant conditions, allowing the peptides to retain func-
tionality [reviewed by 105]. A low background of protein
adsorption can be achieved by adjusting the density and
length of the polymer chain “bristles” [106] while spacers
of different molecular lengths ensure appropriate pre-
sentation of peptide ligands [107]. Importantly, polymerscaffolds are optically transparent which allows for facile
visual assessment of live cell cultures. Protein low-fouling
polymer brushes could be developed into commercially vi-
able culture surfaces for hPSC maintenance and also for
novel differentiation protocols because radical polymerisa-
tion methods allow them to be inexpensively and consist-
ently produced at scale. Further, polymer brushes can be
applied to a range of materials including surfaces with
complex geometries, which make them relevant to poten-
tial future applications including microcarrier suspension
cultures, which are discussed below.
Three dimensional (3D) hPSC culture systems
3D culture systems include hydrogels and suspension
cultures and are of increasing interest to the field due to
the economies of scale involved. These culture systems
produce superior expansion rates and yields to trad-
itional two dimensional (2D) culture systems. While the
more immediate applications for hPSCs are likely to be
drug screening and disease modelling, which require
fewer cells and could be approached with conventional
2D culture systems; clinical applications demand higher
cell numbers and more stringently defined culture con-
ditions for reasons of safety. Well-optimised 3D culture
systems are therefore expected to be indispensible for
generating the quality and quantity of cells required for
clinical applications of hPSCs. For example, repair of a
typical myocardial infarction has been estimated to re-
quire 1–2 billion (x109) cells [108]. Standard two dimen-
sional (2D) culture systems routinely produce cell
densities of ~2x105 cells/cm2 such that 5000-10000 cm2
of culture surface would be needed to generate enough
cells to treat a single myocardial infarction [109] (see
Table 3 for costings). Conversely, suspension culture
of hPSCs has been reported at culture densities of
6.1x106cells/ml and producing a 20-fold expansion in
7 days compared to the 11.3-fold expansion for 2D culture
[110]. In order to generate the requisite number of hPSCs
to repair a single myocardial infarction using a multi-stage
bioreactor system a much more manageable 200 ml cul-
ture volume would be needed [111].
Hydrogels
Hydrogels are three-dimensional structures composed of
cross-linked, hydrophilic, polymeric scaffolds which expand
into an ECM-like gel state when exposed to water. Hydro-
gels have a wide range of potential uses in tissue engineer-
ing [reviewed in 114]. For cell culture thin hydrogels can be
used as an effectively 2D culture substrate where the cells
are present on the surface only or thicker hydrogels can be
used to encapsulate cells, allowing them to proliferate and
migrate within the gel [114]. Like their constituent poly-
mers, hydrogels can be inherently bioactive or relatively
inert. Hydrogels can also be composed of multiple polymer
Table 3 Culture surface coating requirements and costing for the generation of 1 billion (x109) hPSCs




Cost per 1 trillion cells
(5000 cm2) ($USD)














Gibco® [73] $0.0413 $205
Cat No: A14701SA
Recombinant human fibronectin Abcam [113] $0.664 $3320
Cat No: AB92798






Primorigen handbook $0.081 $406
Calculations were based on a typical cell density of 2x105 cells/cm2. These calculations do not take into account requirements for media or plasticware or the
implementation of cardiomyocyte differentiation protocols. It should also be noted that such protocols are not 100% efficient, so it is likely that additional cells
would be required.
1Prices were obtained from the websites of Australian suppliers of the manufacturers listed and converted from $AUD to $USD on the ninth of April 2013
($1AUD =1.04$USD).
2Only concentrations of ECMPs in solution were reported so a volume of 50ul/cm2 was used for calculations, based on recommendations for MatrigelTM coatings
(Becton Dickinson).
3At the time of writing recombinant vitronectin was being promoted in combination with the hPSC media E8 and as such was being sold at low cost.
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incorporate cell-binding motifs [114].
Hyaluronic acid- [67,115] and polyacrylamide-based
hydrogels [15] as well as amino-propylmethacrylamide
hydrogels [14] have been demonstrated to support long-
term culture of hPSCs. These hydrogels interact with
hPSCs through non-specific protein adsorption [14],
pre-coated ECMPs [15] or combinations of the two [67].
Hydrogels incorporating sulfonyl-containing polymer
chains like PSS(S) have also been shown to support long
term culture of hPSCs, presumably by mimicking HSPGs
[102]. Interestingly hydrogels incorporating PMEDSAH
failed to support hPSC adhesion as did several other
sulfonyl-containing hydrogels [102]. With respect to hy-
drogels presenting specific cell-binding ligands, semi-
interpenetrating polymer network hydrogels presenting an
RGD-motif have been shown to enable hPSC-binding
[116]. However these gels were also protein-fouling, used
with MEF-CM and were not tested in longer-term culture
[116]. A (meth)acrylate-based hydrogel modified to present
vitronectin-derived RGD-containing peptides is currently
commercially available as the hPSC culture surface Corning
SynthemaxTM although the protein fouling properties
of this hydrogel have not been published. A study using
a polyacrylamide hydrogel modified with a vitronectin-
derived HSPG-binding peptide recently demonstrated the
first example of long-term self-renewal of hPSCs capable
of in vitro differentiation into the three germ layers,cultured on protein low-fouling, peptide-presenting hydrogels
with modifiable physical properties in defined medium [92].
This provides an interesting tool for controlling self-renewal
of hPSCs in a chemically-defined hydrogel culture system.
hPSC suspension culture systems
Suspension culture systems involve either cell-adherent
microcarriers [117] or free-floating clumps of hPSCs [111]
that are held in suspension by either shaking or stirred
suspension bioreactors. The details of this area are beyond
the scope of this review and have been well-reviewed else-
where [118,119] but the potential applications of these
culture systems cannot be ignored. Briefly, current chal-
lenges for hPSC suspension culture systems include redu-
cing shear forces, maintaining even cell distribution across
microcarriers and passaging expanding cell aggregates
[118]. Due to the potential gains and economies of scale
involved, all work on hPSC culture surfaces and CAM/
ECMP interactions should be undertaken with adaptation
to fully-defined microcarrier-based suspension culture
systems in mind. Protein coatings and polymer scaffolds
can also be readily adapted to microcarrier -based suspen-
sion culture systems [120].
Comparisons of hPSCs cultured on different surfaces and
future directions
Studies comparing defined surfaces have so far been fo-
cused on identifying culture conditions that were equally
Table 4 Ligand-CAM interactions reported to support long-term hPSC culture
Substrates Ligands or ECMPs CAM(s) References
Tissue culture polystyrene (TCP) Vitronectin αVβ3/5 integrins, GAGs [7]
Laminin-511 α6β1 integrin [11]
Laminin E8 fragments - [13]
Fibronectin α5β1 integrin [48]
Collagen + fibronectin + laminin + vitronectin - [125]
Poly(L-lysine) - [126]
E-cadherin-IgG1Fc (StemAdhereTM) E-cadherin [10]
Amine-modified TCP Cyclic-CRGDC - [86]
UV-treated TCP Adsorbed serum proteins, vitronectin - [12]
Acrylate monomer-coated TCP KGGNGEPRGDTYRAY αVβ5 [9]
(Corning SynthemaxTM) integrins - αVβ3/5 [9]
KGGPQVTRGDVFTMP
Vitronectin integrins, GAGs [42]
Self-assembled monolayers GKKQRFRHRNRKG HSPGs [79]
LTTAPKLPKVTR GAGs [127]
Amino-propylmethacrylamide BSA + non-specific proteins (adsorbed from media) - [14]
Hydrogels
Polyacrylamide hydrogel GKKQRFRHRNRKG HSPGs [92]
PMEDSAH Unknown. Adsorbed growth factors? - [99]
Surfaces are arranged according to their substrate. The ligands or extracellular matrix proteins (ECMPs) that are presented from those substrates and the CAMs
with which they have been shown to interact (if any) are also listed. Whole ECMPs, ECMP fragments, fusion proteins, and peptides presented by amine-modified
or acrylate monomer coated TCP, protein-fouling hydrogels and polymers have all demonstrated the capacity to support hPSC culture by interacting with various
integrins, E-cadherins and/or heparan sulphate proteoglycans. The surfaces listed have all been reported to support hPSC culture subject to at least the minimum
cell characterisation requirements outlined in Table 1. Key references have been provided for each surface.
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ing the fundamental goals of hPSC culture such as pro-
moting cell adhesion, proliferation and expression of key
pluripotency markers [15,16,74]. These studies used dif-
ferent combinations of surfaces and media without per-
forming comprehensive cross-comparisons [16], were
more focused on optimising culture media [17] and/or
did not characterise and compare the cells at a high level
of detail. Many of these studies also used whole ECMPs
with multiple binding sites so they were unable to inves-
tigate the role of CAMs in maintaining pluripotency,
and little characterisation of surface properties was per-
formed. Some recent studies have included more de-
tailed characterisation of hPSCs as they are cultured in
various complex, undefined culture systems and have
identified genetic and epigenetic changes that take
place during adaptation to changes in culture condi-
tions [121,122]. While the phenotypic changes were
fairly minor and their causes and/or effects unclear,
greater variation could be expected between the products
of chemically-defined culture systems. It is therefore im-
portant that both cell and surface are characterised thor-
oughly during development of culture systems. Now that
a range of defined culture surfaces have been reported to
support maintenance of hPSCs to a level equivalent toMatrigelTM by the minimum criteria and that the ligands
involved have been identified, it should be possible to
compare the resulting cells in more detail and to optimise
surfaces for hPSC culture systems by taking into consider-
ation the importance of CAM-mediated interactions, of
physicochemical surface properties and of cost. Other fu-
ture directions for defined culture surfaces associated with
hPSCs include applications to directed differentiation pro-
tocols and to the reprogramming of somatic cell types as
changes to CAM expression have been identified during
differentiation [28] and reprogramming [123]. Identifica-
tion of these changes and their role(s) in differentiation
should be instructive for current approaches to developing
inductive biomaterials for differentiation protocols {com-
prehensively reviewed in [124]}.
Conclusions
Pluripotency is a complex state maintained in vitro by
molecular signals received from the cellular microenvir-
onment, including the cell culture surface. Commonly
implemented hPSC culture surfaces are composed of
complex animal products presenting undefined ligands
that interact with many CAMs on the cell surface and
transmit pluripotency-supporting molecular signals to
the nucleus [3-5]. hPSC culture surfaces have evolved
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surface interactions and no potential for use at scale to
purified human recombinant ECMPs including laminin,
fibronectin, vitronectin and HSPGs. Such ECMP-coated
surfaces are xeno-free and interact with hPSCs through
smaller sets of CAM/ligand interactions that are ECMP-
specific, however production of recombinant proteins is
expensive. Furthermore, synthetic surfaces are being de-
veloped based on the functional subunits of ECMPs and
these surfaces have been reported to maintain pluripo-
tency through more specific interactions (see Table 4 for
examples). Defined surfaces thought to specifically interact
with hPSCs through different CAMs appear to be equally
supportive of culture, although direct and detailed com-
parisons between hPSCs maintained on surfaces that
interact with different CAMs have not been performed.
Identifying the role(s) of CAMs in maintaining pluripo-
tency will be an important step towards developing de-
fined, affordable, xeno-free culture conditions for hPSCs
suitable for clinically relevant large scale hPSC culture.
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